87 related articles for article (PubMed ID: 29974056)
1. Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience.
Matejko B; Kukułka A; Kieć-Wilk B; Stąpór A; Klupa T; Malecki MT
Adv Med; 2018; 2018():1473160. PubMed ID: 29974056
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
3. Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents.
Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):198-203. PubMed ID: 33374094
[TBL] [Abstract][Full Text] [Related]
4. Are late-night eating habits and sleep duration associated with glycemic control in adult type 1 diabetes patients treated with insulin pumps?
Matejko B; Kiec-Wilk B; Szopa M; Trznadel Morawska I; Malecki MT; Klupa T
J Diabetes Investig; 2015 Jul; 6(4):460-4. PubMed ID: 26221525
[TBL] [Abstract][Full Text] [Related]
5. Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus.
Lau YN; Korula S; Chan AK; Heels K; Krass I; Ambler G
Pediatr Diabetes; 2016 Aug; 17(5):319-26. PubMed ID: 25998469
[TBL] [Abstract][Full Text] [Related]
6. Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.
Kapellen TM; Heidtmann B; Lilienthal E; Rami-Merhar B; Engler-Schmidt C; Holl RW
Diabetes Technol Ther; 2015 Dec; 17(12):872-9. PubMed ID: 26509360
[TBL] [Abstract][Full Text] [Related]
7. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of insulin pump treatment in adult T1DM patients--influence of age and social environment.
Grzanka M; Matejko B; Cyganek K; Kozek E; Małecki MT; Klupa T
Ann Agric Environ Med; 2012; 19(3):573-5. PubMed ID: 23020059
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Insulin Pump Therapy on Diabetes Treatment Satisfaction and Glycemic Control Among Patients with Type 1 Diabetes Mellitus in Saudi Arabia: A Prospective Study.
Al Hayek AA; Robert AA; Al Dawish MA; Braham RB; Goudeh HS; Al Sabaan FS
Diabetes Ther; 2015 Jun; 6(2):227-36. PubMed ID: 25924588
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
11. Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump.
Ucieklak D; Mrozinska S; Wojnarska A; Malecki MT; Klupa T; Matejko B
Int J Endocrinol; 2022; 2022():9169296. PubMed ID: 35111222
[TBL] [Abstract][Full Text] [Related]
12. Clinical factors affecting the perception of hypoglycemia in type 1 diabetes patients treated with personal insulin pumps.
Matejko B; Grzanka M; Kieć-Wilk B; Małecki MT; Klupa T
Ann Agric Environ Med; 2013; 20(1):152-4. PubMed ID: 23540230
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of continuous subcutaneous insulin infusion in adults with type 1 diabetes mellitus patients: Results of a public healthcare system.
Moreno-Fernandez J; López LM; Gomez FJ; Pinés P; Blanco B; González J; López J; Herranz S; Roa C; Gómez-Romero FJ
Endocrinol Diabetes Nutr (Engl Ed); 2021 Feb; 68(2):116-122. PubMed ID: 32007441
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
[TBL] [Abstract][Full Text] [Related]
15. WHICH FACTORS MAY AFFECT THE QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING THE MEDTRONIC VEO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP?
Thomakos P; Panagopoulos G; Kepaptsoglou O; Zoupas C; Mitrakou A
Georgian Med News; 2018 Apr; (277):61-67. PubMed ID: 29745917
[TBL] [Abstract][Full Text] [Related]
16. Insulin pumps use in Greece: Efficacy and safety data from 140 patients with type 1 diabetes mellitus.
Somali M; Paschou SA; Mouslech Z
Diabetes Res Clin Pract; 2020 Feb; 160():108026. PubMed ID: 31954749
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitus.
Brancato D; Fleres M; Aiello V; Saura G; Scorsone A; Ferrara L; Provenzano F; Di Noto A; Spano L; Provenzano V
Diabetes Technol Ther; 2014 Nov; 16(11):735-41. PubMed ID: 25162664
[TBL] [Abstract][Full Text] [Related]
18. Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM).
Brož J; Janíčková Žďárská D; Urbanová J; Brabec M; Doničová V; Štěpánová R; Martinka E; Kvapil M
Diabetes Ther; 2018 Oct; 9(5):1897-1906. PubMed ID: 30094784
[TBL] [Abstract][Full Text] [Related]
19. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Insulin Pump Therapy and Its Association with Measures of Glycemic Control: Results from the Canadian Study of Longevity in Type 1 Diabetes.
Boulet G; Halpern EM; Lovblom LE; Weisman A; Bai JW; Eldelekli D; Keenan HA; Brent MH; Paul N; Bril V; Cherney DZ; Perkins BA
Diabetes Technol Ther; 2016 May; 18(5):298-307. PubMed ID: 27023749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
